Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAPN1 | P07384 | 1/20 | 0.55 |
| ▸ | MME | P08473 | 1/20 | 0.55 |
| ▸ | ANPEP | P15144 | 1/20 | 0.55 |
| ▸ | LTA4H | P09960 | 1/20 | 0.54 |
| ▸ | FNTA | P49354 | 1/20 | 0.54 |
| ▸ | FNTB | P49356 | 1/20 | 0.54 |
| ▸ | CTSL | P07711 | 5/20 | 0.53 |
| ▸ | CTSB | P07858 | 3/20 | 0.53 |
| ▸ | REN | P00797 | 1/20 | 0.53 |
| ▸ | CTSS | P25774 | 1/20 | 0.53 |
| ▸ | CTSK | P43235 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28820287 | 0.95 | FNTA (0.58) | CAPN1MMEANPEPLTA4HFNTA | |
| SCHEMBL9324447 | 0.95 | FNTA (0.58) | CAPN1MMEANPEPLTA4HFNTA | |
| SCHEMBL2502296 | 0.94 | CTSL (0.60) | MMEANPEPLTA4HFNTAFNTB | |
| SCHEMBL4706198 | 0.89 | MME (0.61) | CAPN1MMEANPEPLTA4HFNTA | |
| SCHEMBL11705090 | 0.88 | FNTA (0.62) | MMEANPEPLTA4HFNTAFNTB | |
| SCHEMBL11705092 | 0.88 | FNTA (0.62) | MMEANPEPLTA4HFNTAFNTB | |
| SCHEMBL9830575 | 0.87 | CAPN1 (0.62) | CAPN1MMECTSLCTSBREN | |
| SCHEMBL1436898 | 0.87 | CAPN1 (0.62) | CAPN1MMECTSLCTSBREN | |
| SCHEMBL13093340 | 0.86 | CTSL (0.58) | CAPN1MMEANPEPFNTAFNTB | |
| SCHEMBL6379430 | 0.86 | CAPN1 (0.65) | CAPN1CTSLCTSBRENCTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4703369-A1 | METHOD FOR SYNTHESIZING AMIDE AND/OR POLYPEPTIDE BY USING TEMPORARILY PROTECTED AMINO ACIDS AS AMINE COMPONENTS | GUANGZHOU MEDICAL UNIVERSITY (CN) | 2026-03-04 | — | — | EP | disclosed |
| US-20260008808-A1 | Method for Synthesizing Amide and/or Polypeptide Using Unprotected Amino Acid as Ammonia Component | UNIV GUANGZHOU MEDICAL (CN) | 2026-01-08 | — | — | US | disclosed |
| US-20260001906-A1 | Method for Synthesizing Amide and/or Polypeptide Using Temporary Protected Amino Acid as Ammonia Component | UNIV GUANGZHOU MEDICAL (CN) | 2026-01-01 | — | — | US | disclosed |
| EP-4574834-A1 | METHOD FOR SYNTHESIZING AMIDE AND/OR POLYPEPTIDE WITH UNPROTECTED AMINO ACID AS AMINE COMPONENT | GUANGZHOU MEDICAL UNIVERSITY (CN) | 2025-06-25 | — | — | EP | disclosed |
| CN-119371478-A | Method for synthesizing amide and/or polypeptide by taking transient protection amino acid as ammonia component | 广州医科大学 | 2025-01-28 | — | — | CN | disclosed |
| WO-2025015659-A1 | METHOD FOR SYNTHESIZING AMIDE AND/OR POLYPEPTIDE BY TAKING TRANSIENTLY PROTECTED AMINO ACID AS AMMONIA COMPONENT | 广州医科大学 | 2025-01-23 | — | — | WO | disclosed |
| WO-2024229918-A1 | METHOD FOR SYNTHESIZING AMIDE AND/OR POLYPEPTIDE BY USING TEMPORARILY PROTECTED AMINO ACIDS AS AMINE COMPONENTS | 广州医科大学 | 2024-11-14 | — | — | WO | disclosed |
| WO-2024139061-A1 | METHOD FOR SYNTHESIZING AMIDE AND/OR POLYPEPTIDE WITH UNPROTECTED AMINO ACID AS AMINE COMPONENT | 广州医科大学 | 2024-07-04 | — | — | WO | disclosed |
| CN-116675727-A | Method for synthesizing amide and/or polypeptide by taking unprotected amino acid as ammonia component | 广州医科大学 | 2023-09-01 | — | — | CN | disclosed |
| CN-116675726-A | Method for synthesizing amide and/or polypeptide by using temporarily protected amino acid as ammonia component | 广州医科大学 | 2023-09-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260008808-A1 | Method for Synthesizing Amide and/or Polypeptide Using Unprotected Amino Acid as Ammonia Component | ANPEP, PTMS, GCG | CAPN1 1767/4885MME 277/4885ANPEP 1/4885 |
| US-20260001906-A1 | Method for Synthesizing Amide and/or Polypeptide Using Temporary Protected Amino Acid as Ammonia Component | BCAT1, BCAT2, PTMS | CAPN1 2610/4885MME 950/4885ANPEP 7/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.